drugset / Trial / NCT00216450

Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.

NCT00216450

Phase 4 Completed 80 enrolled Janssen Cilag Pharmaceutica S.A.C.I., Greece
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to confirm the safety and effectiveness of rabeprazole in the treatment of adult patients with Helicobacter pylori (H. pylori) infection in routine clinical practice.

Timeline

Start
2004-10
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabeprazole Small molecule 20 mg Oral